Live Breaking News & Updates on Takeda Refer Company|Page 9

Stay updated with breaking news from Takeda refer company. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Takeda: European Commission Grants Marketing Authorization For Dengue Vaccine, QDENGA

TOKYO (dpa-AFX) - Takeda (TAK) announced the European Commission granted marketing authorization for the company's dengue vaccine QDENGA for the prevention of dengue disease in individuals from ....

European Union , European Commission , European Medicines Agency , More Such Health News ,

Takeda Pharmaceutical Company Limited: Takeda's QDENGA? (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

The European Commission Approved QDENGA (TAK-003) for Use in Individuals Four Years of Age and Olderi QDENGA Becomes the Only Dengue Vaccine Approved in the EU for Use in Individuals Regardless of Previous ....

Sri Lanka , United States , Dominican Republic , Gary Dubin , Rachel Higgins , Tomas Jelinek , Jun Saito , European Commission , World Health Organization , International Media , Berlin Centre For , Data Monitoring Committee , Exchange Commission , European Commission Approved , European Union Eu Member States , European Union , Takeda Pharmaceutical Company Limited , European Centre For Disease Prevention , Individuals Four Years , Only Dengue Vaccine Approved , Individuals Regardless , Previous Dengue , Dengue Tetravalent Vaccine , European Medicines Agency , Medicinal Products , Human Use ,

Takeda's Dengue Vaccine 'Qdenga' Receives Approval from Europe

European Commission approved Takeda's new dengue vaccine 'Qdenga' for ages four and above. ....

Christophe Weber , Trisha Kae Andrada , Takeda Pharmaceutical Co , European Commission , World Health Organization , Us Centers For Disease , Tech Times , Takeda Pharmaceutical , Wall Street Journal , Tokyo Based Takeda , New England Journal , Disease Control , Takeda Pharmaceutical , Dengue Vaccine ,

Takeda: FDA Grants Priority Review Of BLA For Dengue Vaccine Candidate TAK-003

TOKYO (dpa-AFX) - Takeda (TAK) said that the U.S. Food and Drug Administration has granted priority review of the Biologics License Application for TAK-003, the company's investigational dengue ....

Puerto Rico , American Samoa , United States , Drug Administration , More Such Health News , Biologics License Application , Latin America ,

Takeda findings may minimise haemophilia treatment side effects

Research from Takeda and Institute Krems Bioanalytics of IMC Krems and will help treat patients - News - PharmaTimes ....

Christian Lubich , Institute Krems Bioanalytics , University Of Applied Sciences Krems , Applied Sciences Krems ,